AJP - Heart pressure measurements
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 277: H515-H523, 1999;
0363-6135/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujita, N.
Right arrow Articles by Saito, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujita, N.
Right arrow Articles by Saito, T.
Vol. 277, Issue 2, H515-H523, August 1999

Failure of cdc2 promoter activation and G2/M transition by ANG II and AVP in vascular smooth muscle cells

Nobuya Fujita1, Yusuke Furukawa2, Naoki Itabashi1, Yasushi Tsuboi1, Michio Matsuda2, Koji Okada1, and Toshikazu Saito1

1 Division of Endocrinology and Metabolism, Department of Medicine, and 2 Division of Molecular Hemopoiesis, Center for Molecular Medicine, Jichi Medical School, Tochigi 329-0498, Japan

The physiological role of the vasoconstrictive hormones arginine vasopressin (AVP) and angiotensin II (ANG II) in the development of vascular hyperplasia is still unclear. We examined the effects of these hormones on cell cycle regulation of cultured rat vascular smooth muscle cells (VSMC). AVP and ANG II were able to induce G1/S transition and DNA synthesis in serum-starved quiescent VSMC but failed to promote further progression into G2/M phases. AVP and ANG II enhanced the expression and activity of cdk2, cyclin E, and proliferating cell nuclear antigen but did not induce expression of cdc2/cyclin B complex, a critical regulator of G2/M transition. The failure of cdc2 mRNA induction was found to be caused by a defect in cdc2 promoter activation. Binding of free E2F-1 to the cdc2 promoter did not occur in hormone-treated VSMC, which may account for the defective induction of cdc2. The absence of cdc2 promoter activation and G2/M transition may be important for the prevention of hyperplasia under physiological conditions but underlies the hypertrophy of VSMC.

cell cycle; proliferating cell nuclear antigen; cyclin; E2F-1


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Fujita, Y. Furukawa, N. Itabashi, K. Okada, T. Saito, and S. Ishibashi
Differences in E2F subunit expression in quiescent and proliferating vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H204 - H212.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online